Hangzhou Tigermed Consulting Co., Ltd(stock symbol: 300347) is a leading Contract Research Organization (CRO) in China dedicated to provide professional full clinical trial services. Tigermed has been committed to accelerating medical product development with costs efficiency and quality. Headquartered in Hangzhou, Tigermed operates 97 offices in China, including one in Hong Kong China and one in Taiwan China. And 9 overseas offices in Korea,Japan and Romania etc. with over 5000 full time staffs. Tigermed has serviced more than 600 local and global clients in the conduct of over 1500 clinical trials. Tigermed is recognized as “The Innovative CRO” in China,owning to our involvement of over 100 innovative drugs.